DDInter1888 DDInter1665
An essential amino acid that is necessary for normal growth in infants and for nitrogen balance in adults. It is a precursor of indole alkaloids in plants. It is a precursor of serotonin (hence its use as an antidepressant and sleep aid). It can be a precursor to niacin, albeit inefficiently, in mammals.
Sibutramine (trade name Meridia in the USA, Reductil in Europe and other countries), usually as sibutramide hydrochloride monohydrate, is an orally administered agent for the treatment of obesity. It is a centrally acting stimulant chemically related to amphetamines thus it is classified as a Schedule IV controlled substance in the United States. In October 2010, Sibutramine was withdrawn from Canadian and U.S. markets due to concerns that the drug increases the risk of heart attack and stroke in patients with a history of heart disease.
Tryptophan {u} (Compound) resembles {v} (Compound) Oxitriptan
Oxitriptan {u} may lead to a major life threatening interaction when taken with {v} Sibutramine
Tryptophan {u} (Compound) resembles {v} (Compound) L-Phenylalanine
L-Phenylalanine {u} (Compound) resembles {v} (Compound) Oxitriptan
Oxitriptan {u} may lead to a major life threatening interaction when taken with {v} Sibutramine
Tryptophan {u} (Compound) resembles {v} (Compound) Oxitriptan
Oxitriptan {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Cyproheptadine
Cyproheptadine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Sibutramine
Tryptophan {u} (Compound) resembles {v} (Compound) L-Histidine
L-Histidine {u} (Compound) resembles {v} (Compound) Oxitriptan
Oxitriptan {u} may lead to a major life threatening interaction when taken with {v} Sibutramine
Tryptophan {u} (Compound) resembles {v} (Compound) L-Phenylalanine
L-Phenylalanine {u} (Compound) resembles {v} (Compound) Nateglinide
Nateglinide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Sibutramine
Tryptophan {u} (Compound) resembles {v} (Compound) Levodopa
Levodopa {u} (Compound) resembles {v} (Compound) Levonordefrin
Levonordefrin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Sibutramine
Tryptophan {u} (Compound) resembles {v} (Compound) Oxitriptan
Oxitriptan {u} may lead to a major life threatening interaction when taken with {v} Procarbazine
Procarbazine {u} may lead to a major life threatening interaction when taken with {v} Sibutramine
Tryptophan {u} (Compound) resembles {v} (Compound) L-Tyrosine
L-Tyrosine {u} (Compound) resembles {v} (Compound) Metyrosine
Metyrosine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Sibutramine
Tryptophan {u} (Compound) resembles {v} (Compound) Levodopa
Levodopa {u} (Compound) causes {v} (Side Effect) Salivary hypersecretion
Salivary hypersecretion {u} (Side Effect) is caused by {v} (Compound) Sibutramine
Tryptophan {u} (Compound) resembles {v} (Compound) L-Phenylalanine
L-Phenylalanine {u} (Compound) resembles {v} (Compound) Mephentermine
Mephentermine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Sibutramine
Tryptophan (Compound) resembles Oxitriptan (Compound) and Oxitriptan may lead to a major life threatening interaction when taken with Sibutramine
Tryptophan (Compound) resembles L-Phenylalanine (Compound) and L-Phenylalanine (Compound) resembles Oxitriptan (Compound) and Oxitriptan may lead to a major life threatening interaction when taken with Sibutramine
Tryptophan (Compound) resembles Oxitriptan (Compound) and Oxitriptan may cause a moderate interaction that could exacerbate diseases when taken with Cyproheptadine and Cyproheptadine may cause a moderate interaction that could exacerbate diseases when taken with Sibutramine
Tryptophan (Compound) resembles L-Histidine (Compound) and L-Histidine (Compound) resembles Oxitriptan (Compound) and Oxitriptan may lead to a major life threatening interaction when taken with Sibutramine
Tryptophan (Compound) resembles L-Phenylalanine (Compound) and L-Phenylalanine (Compound) resembles Nateglinide (Compound) and Nateglinide may cause a moderate interaction that could exacerbate diseases when taken with Sibutramine
Tryptophan (Compound) resembles Levodopa (Compound) and Levodopa (Compound) resembles Levonordefrin (Compound) and Levonordefrin may cause a moderate interaction that could exacerbate diseases when taken with Sibutramine
Tryptophan (Compound) resembles Oxitriptan (Compound) and Oxitriptan may lead to a major life threatening interaction when taken with Procarbazine and Procarbazine may lead to a major life threatening interaction when taken with Sibutramine
Tryptophan (Compound) resembles L-Tyrosine (Compound) and L-Tyrosine (Compound) resembles Metyrosine (Compound) and Metyrosine may cause a moderate interaction that could exacerbate diseases when taken with Sibutramine
Tryptophan (Compound) resembles Levodopa (Compound) and Levodopa (Compound) causes Salivary hypersecretion (Side Effect) and Salivary hypersecretion (Side Effect) is caused by Sibutramine (Compound)
Tryptophan (Compound) resembles L-Phenylalanine (Compound) and L-Phenylalanine (Compound) resembles Mephentermine (Compound) and Mephentermine may cause a moderate interaction that could exacerbate diseases when taken with Sibutramine